Navigation Links
Fink receives Gruber Genetics Prize, lectures at American Society of Human Genetics annual meeting
Date:11/2/2010

November 4, New York, NY No one knows better "The Promise of Human Genetics" than the man who will address that topic at a conference in Washington D.C. on Wednesday: this year's Gruber Genetics Prize recipient Prof. Gerald R. Fink.

It is Fink who discovered how to "grow" genes in yeast, thus allowing scientists to create and study a never‐ending series of DNA scenarios and track how cells inherit information. It is Fink whose "transforming" technique effectively opened a biological factory to produce insulin, vaccines and other medical products. It is Fink and his colleagues who discerned the genetic mechanisms by which certain disease‐bearing fungi switch from benign to infectious, thereby setting the stage for an unprecedented defense of the immune system. And it is Fink who has generously shared his work with other scientists and who continues to teach the next generation of researchers.

He will deliver the Gruber Lecture at the annual meeting of the American Society of Human Genetics, immediately after accepting the $500,000 Genetics Prize from The Peter and Patricia Gruber Foundation.

The son of a medical doctor, Fink was born in New York 70 years ago. He majored in biology at Amherst College and earned his PhD in genetics from Yale University. He taught at Cornell University for 15 years before moving to the Massachusetts Institute of Technology in 1982, where he continues to research and teach. He is also associated with the Whitehead Institute for Biomedical Research.

Additional Information:

The official citation to the Prize reads: The Peter and Patricia Gruber Foundation proudly presents the 2010 Genetics Prize to Gerald R. Fink, Ph.D., a founder of modern yeast genetics and a leader in the use of model‐organism genetics to study diverse biological problems. Fink developed a system that allows insertions of laboratory‐modified‐DNA molecules into their natural locations in the yeast chromosomes. His breakthrough technique enabled the genetic dissection of basic cellular processes and the manufacture of drugs and vaccines in yeast, as well as inspiring similar approaches to the genetic manipulation of diverse organisms.

Fink applied the "awesome power" of the new yeast genetics to discover how genomic information is transcribed, recombined, suppressed, transposed, and translated. In his own laboratory, he trained a legion of leading geneticists to apply yeast genetics to advance biomedical science, and inspired many more to do so through his teaching and writing.


'/>"/>

Contact: Alyson O'Mahoney
aomahoney@robinleedyassociates.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related biology news :

1. U of I receives $1.5 million to further sustainability in ornamental crop production
2. La Jolla Institute scientist Klaus Ley receives Malpighi award
3. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
4. Virginia Techs Mueller receives friendship award from China
5. Aeras-led research consortium receives FDA support
6. UNC scientist receives NIH directors New Innovator Award
7. RIT receives federal grant to construct new sustainability research facility
8. UCLA receives $12.5M to lead international project to study proteins implicated in heart disease
9. Einstein receives $30 million to study protein form and function
10. Prof. Xiaoguang Meng receives honorary master of engineering from Stevens
11. LSU receives $15 million grant from NIH to build biomedical research pipeline for Louisiana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , Jan. 8, ... of innovative sensor-based diagnostic products, today announced the closing of ... and existing investors.  Proceeds from the financing will be used ... a hand-held device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/3/2016)... , Feb. 3, 2016  With the ... patent cliff that is underway, therapies such as ... for a whole host of indications are in ... aid in the development and production of these ... poor quality and high costs, novel approaches and ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... to aid in the rapid development and ongoing quality control of molecular assays ... outbreak is extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, ...
Breaking Biology Technology: